Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and

Udo Sechtem1, David Brown2, Shigeo Godo3

  • 1Department of Cardiology, Robert Bosch Krankenhaus, Auerbachstr. 110, D-70376 Stuttgart, Germany.

Cardiovascular Research
|January 21, 2020
PubMed

Insights

Coronary artery disease (CAD) often involves epicardial disease and coronary microvascular dysfunction (CMD). Recognizing CMD is crucial for understanding persistent symptoms and improving prognostic assessments in patients with CAD.

Area of Science:

  • Cardiology
  • Vascular Biology

Background:

  • Coronary artery disease (CAD) can present as diffuse or focal epicardial disease, often coexisting with coronary microvascular abnormalities.
  • Distinguishing the independent and combined contributions of epicardial disease and coronary microvascular dysfunction (CMD) in the coronary circulation is clinically challenging.

Purpose of the Study:

  • This review aims to address the complexities in identifying CMD within the spectrum of non-obstructive and obstructive CAD.
  • It will explore the pathophysiology, clinical context, and diagnostic approaches for CMD in patients with CAD.

Main Methods:

  • Literature review focusing on the pathophysiology and clinical presentation of CMD in conjunction with epicardial CAD.
  • Discussion of non-invasive diagnostic modalities for evaluating coronary microvascular function.

Main Results:

  • Coronary microvascular dysfunction (CMD) is an important, often overlooked, factor in patients with coronary artery disease (CAD).
  • CMD may explain persistent symptoms and the prognostic significance of global coronary flow reserve over single-vessel fractional flow reserve.

Conclusions:

  • Accurate identification of CMD is essential for comprehensive patient assessment and management in CAD.
  • Understanding the interplay between epicardial disease and CMD is critical for improving treatment strategies and patient outcomes.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
309
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
805
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
256
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
191
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
407